Vivo Capital

Latest statistics and disclosures from Vivo Capital's latest quarterly 13F-HR filing:

Tip: Access up to 7 years of quarterly data

Positions held by Vivo Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Vivo Capital

Companies in the Vivo Capital portfolio as of the December 2020 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
ALX Oncology Holdings Common (ALXO) 16.2 $364M 4.2M 86.20
Ascendis Pharma A/S Sponsored Adr (ASND) 13.4 $300M 1.8M 166.78
Harmony Biosciences Holdings Common (HRMY) 7.3 $164M 4.5M 36.15
Tarsus Pharmaceuticals Common (TARS) 6.0 $134M NEW 3.2M 41.33
New Frontier Health Corp Ord Shs (NFH) 5.5 $123M 14M 8.60
Aligos Therapeutics Common (ALGS) 4.4 $98M NEW 3.5M 27.65
Genetron Holdings Ads (GTH) 4.0 $89M 6.3M 14.00
Amyris Common (AMRS) 3.6 $81M 13M 6.17
Legend Biotech Corp Sponsored Sponsored Ads (LEGN) 3.5 $78M -17% 2.8M 28.16
Olema Pharmaceuticals Common (OLMA) 2.7 $60M NEW 1.2M 48.08
Iveric Bio Common (ISEE) 1.8 $41M 6.0M 6.91
Sinovac Biotech SHS (SVA) 1.7 $38M 5.9M 6.47
Passage Bio Common (PASG) 1.7 $38M -32% 1.5M 25.57
Crinetics Pharmaceuticals Common (CRNX) 1.5 $33M +3% 2.3M 14.11

Setup an alert

Vivo Capital will file the next quarterly 13-HR in about 1 months. Would you like to be notified?

Nkarta Common (NKTX) 1.4 $32M 512k 61.47
Sierra Oncology Common (SRRA) 1.4 $31M 1.9M 16.03
KalVista Pharmaceuticals Common (KALV) 1.4 $31M +9% 1.6M 18.99
Arcutis Biotherapeutics Common (ARQT) 1.1 $24M -22% 867k 28.13
Kadmon Holdings Common (KDMN) 1.1 $24M +9% 5.8M 4.15
Zai Lab Adr (ZLAB) 1.1 $24M +43% 175k 135.34
Avadel Pharmaceuticals Adr (AVDL) 1.1 $24M 3.5M 6.68
Celldex Therapeutics Common (CLDX) 1.0 $23M -25% 1.3M 17.52
Essa Pharma Common (EPIX) 1.0 $23M +24% 1.9M 11.93
Eiger BioPharmaceuticals Common (EIGR) 1.0 $22M 1.8M 12.29
Verona Pharma Ads (VRNA) 1.0 $21M 3.0M 7.00
Zogenix Common (ZGNX) 0.9 $20M +23% 1.0M 19.99
Chinook Therapeutics Common (KDNY) 0.9 $19M NEW 1.2M 15.86
Novavax Common (NVAX) 0.8 $18M -4% 158k 111.51
Kura Oncology Common (KURA) 0.8 $17M -49% 525k 32.66
Larimar Therapeutics Common (LRMR) 0.8 $17M 800k 21.41
Rocket Pharmaceuticals Common (RCKT) 0.8 $17M -63% 311k 54.84
Akero Therapeutics Common (AKRO) 0.7 $16M +10% 633k 25.80
Immunovant Common (IMVT) 0.7 $16M -66% 348k 46.19
Arrowhead Pharmaceuticals Common (ARWR) 0.7 $16M -64% 205k 76.73
Mereo Biopharma Group Ads (MREO) 0.7 $15M -32% 4.2M 3.58
Cytokinetics Common (CYTK) 0.6 $15M 700k 20.78
Zymeworks Common (ZYME) 0.6 $14M -55% 286k 47.26
Curis Common (CRIS) 0.5 $12M NEW 1.4M 8.19
Aclaris Therapeutics Common (ACRS) 0.5 $11M 1.6M 6.47
Calliditas Therapeutics Sponsored Ads (CALT) 0.5 $11M -46% 311k 33.62
Poseida Therapeutics Common (PSTX) 0.5 $10M 926k 10.97
Homology Medicines Common (FIXX) 0.4 $9.6M 853k 11.29
Matinas Biopharma Hldgs Common (MTNB) 0.4 $8.8M -42% 6.5M 1.36
Codexis Common (CDXS) 0.4 $8.5M -73% 388k 21.83
10X Genomics CL A Common (TXG) 0.4 $8.4M NEW 59k 141.60
Aurinia Pharmaceuticals Common (AUPH) 0.3 $6.9M 501k 13.83
Dyne Therapeutics Common (DYN) 0.3 $6.6M 315k 21.00
Orchard Therapeutics Ads (ORTX) 0.3 $5.7M 1.3M 4.32
Kala Pharmaceuticals Common (KALA) 0.2 $5.3M 787k 6.78
Constellation Pharmaceutical Common (CNST) 0.2 $4.0M 140k 28.80
Atricure Common (ATRC) 0.2 $3.6M 65k 55.67
Cymabay Therapeutics Common (CBAY) 0.1 $3.4M -71% 585k 5.74
Ovid Therapeutics Common (OVID) 0.1 $2.9M 1.3M 2.31
IGM Biosciences Common (IGMS) 0.1 $1.8M -80% 20k 88.30
VYNE Therapeutics Common 0.1 $1.5M -48% 940k 1.58
Tricida Common (TCDA) 0.1 $1.2M 175k 7.05
Precision Biosciences Common (DTIL) 0.1 $1.2M 140k 8.34
Metacrine Common (MTCR) 0.1 $1.2M 146k 7.86
Revolution Medicines Common (RVMD) 0.0 $661k -83% 17k 39.60

Past Filings by Vivo Capital

SEC 13F filings are viewable for Vivo Capital going back to 2016

View all past filings